HUT77437A - Amino-purin antivírusos szerek alkalmazása latens herpeszvírus-fertőzés kezelésére és megelőzésére alkalmas gyógyszerkészítmények előállítására - Google Patents

Amino-purin antivírusos szerek alkalmazása latens herpeszvírus-fertőzés kezelésére és megelőzésére alkalmas gyógyszerkészítmények előállítására

Info

Publication number
HUT77437A
HUT77437A HU9702095A HU9702095A HUT77437A HU T77437 A HUT77437 A HU T77437A HU 9702095 A HU9702095 A HU 9702095A HU 9702095 A HU9702095 A HU 9702095A HU T77437 A HUT77437 A HU T77437A
Authority
HU
Hungary
Prior art keywords
prophylaxis
treatment
pharmaceutical compositions
antiviral agents
compositions useful
Prior art date
Application number
HU9702095A
Other languages
English (en)
Other versions
HU222835B1 (hu
Inventor
Teresa Helen Bacon
Hugh John Field
David Sutton
Alana Maureen Thackray
Richard Anthony Vere Hodge
Original Assignee
Smithkline Beecham Plc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27451235&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUT77437(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9425012.3A external-priority patent/GB9425012D0/en
Priority claimed from GBGB9506663.5A external-priority patent/GB9506663D0/en
Priority claimed from GBGB9517308.4A external-priority patent/GB9517308D0/en
Application filed by Smithkline Beecham Plc. filed Critical Smithkline Beecham Plc.
Publication of HUT77437A publication Critical patent/HUT77437A/hu
Publication of HU222835B1 publication Critical patent/HU222835B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9702095A 1994-12-12 1995-11-23 Amino-purin antivírusos szerek alkalmazása latens herpeszvírus-fertőzés kezelésére és megelőzésére szolgáló gyógyszerkészítmények hatóanyagaként HU222835B1 (hu)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9425012.3A GB9425012D0 (en) 1994-12-12 1994-12-12 Pharmaceuticals
GBGB9506663.5A GB9506663D0 (en) 1995-03-31 1995-03-31 Pharmaceuticals
GBGB9517308.4A GB9517308D0 (en) 1995-08-24 1995-08-24 Pharmaceuticals
US08/522,790 US5840763A (en) 1994-12-12 1995-09-01 Treatment of a latent infection of herpes viruses
PCT/EP1995/004692 WO1996018396A1 (en) 1994-12-12 1995-11-23 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections

Publications (2)

Publication Number Publication Date
HUT77437A true HUT77437A (hu) 1998-04-28
HU222835B1 HU222835B1 (hu) 2003-11-28

Family

ID=27451235

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9702095A HU222835B1 (hu) 1994-12-12 1995-11-23 Amino-purin antivírusos szerek alkalmazása latens herpeszvírus-fertőzés kezelésére és megelőzésére szolgáló gyógyszerkészítmények hatóanyagaként

Country Status (24)

Country Link
US (2) US5840763A (hu)
EP (1) EP0799039B1 (hu)
JP (1) JP2008088189A (hu)
CN (1) CN1098687C (hu)
AP (1) AP669A (hu)
AT (1) ATE208198T1 (hu)
AU (1) AU699627B2 (hu)
BG (1) BG63815B1 (hu)
BR (1) BR9509986A (hu)
CA (1) CA2207503C (hu)
CY (1) CY2339B1 (hu)
CZ (1) CZ291545B6 (hu)
DE (1) DE69523776T2 (hu)
DK (1) DK0799039T3 (hu)
ES (1) ES2166834T3 (hu)
HK (1) HK1003259A1 (hu)
HU (1) HU222835B1 (hu)
NO (1) NO313862B1 (hu)
NZ (1) NZ297424A (hu)
PT (1) PT799039E (hu)
RO (1) RO120042B1 (hu)
SI (1) SI0799039T1 (hu)
SK (1) SK282983B6 (hu)
WO (1) WO1996018396A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
US6047209A (en) * 1999-04-02 2000-04-04 Denny; Jeffrey Paul Method and apparatus for maintenance of pierced orifices
CA2602691A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
EP3753563A1 (en) * 2019-06-20 2020-12-23 Helmholtz-Zentrum für Infektionsforschung GmbH Anti-herpesvirus guanosine analogue for the inhibition of basal autophagy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses

Also Published As

Publication number Publication date
SK75197A3 (en) 1997-11-05
SI0799039T1 (en) 2002-06-30
RO120042B1 (ro) 2005-08-30
DE69523776D1 (de) 2001-12-13
BR9509986A (pt) 1997-11-25
BG101608A (en) 1998-02-27
HU222835B1 (hu) 2003-11-28
CZ291545B6 (cs) 2003-04-16
ATE208198T1 (de) 2001-11-15
PT799039E (pt) 2002-04-29
SK282983B6 (sk) 2003-01-09
CN1175212A (zh) 1998-03-04
AU4257896A (en) 1996-07-03
JP2008088189A (ja) 2008-04-17
BG63815B1 (bg) 2003-02-28
DE69523776T2 (de) 2002-08-01
AP9701001A0 (en) 1997-07-31
WO1996018396A1 (en) 1996-06-20
NO313862B1 (no) 2002-12-16
NO972688D0 (no) 1997-06-11
CA2207503A1 (en) 1996-06-20
EP0799039A1 (en) 1997-10-08
CA2207503C (en) 2006-07-18
CZ179997A3 (en) 1997-09-17
CY2339B1 (en) 2004-02-06
EP0799039B1 (en) 2001-11-07
AP669A (en) 1998-09-04
US5840763A (en) 1998-11-24
NZ297424A (en) 2000-07-28
NO972688L (no) 1997-08-07
AU699627B2 (en) 1998-12-10
ES2166834T3 (es) 2002-05-01
DK0799039T3 (da) 2002-01-28
MX9704336A (es) 1997-09-30
US5916893A (en) 1999-06-29
CN1098687C (zh) 2003-01-15
HK1003259A1 (en) 1998-10-23

Similar Documents

Publication Publication Date Title
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
AP9600794A0 (en) Pharmaceutical compositions containing novel compounds and their use in treating allergic and inflammatory diseases
HUP9601161A3 (en) Use of retinoids in cosmetic compositions or for the manufacture of pharmaceutical compositions
EP0707480A4 (en) ANTINEOPLASTIC COMPOSITIONS AND METHOD FOR THEIR USE
HUP9603607A3 (en) Use of triazolidine derivatives for the preparation of pharmaceutical compositions for the treatment and prophylaxis of osteoporosis
AP9300603A0 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
DE3370587D1 (en) Compositions comprising interferon and their therapeutic use
HU9503624D0 (en) Use of p antagonist in pharmaceutical compositions
HK1022269A1 (en) Use of 1-hydroxy-2-pyridones in the manufacture of a medicament for treating skin infections
HUT77437A (hu) Amino-purin antivírusos szerek alkalmazása latens herpeszvírus-fertőzés kezelésére és megelőzésére alkalmas gyógyszerkészítmények előállítására
GB9321341D0 (en) Therapeutic compositions for use in the treatment of skin lesions and method of making same
HUP0001526A3 (en) Use of nucleozides for producing pharmaceutical compositions for cytokine related treatments of disease and the pharmaceutical compositions
GB8926595D0 (en) Pharmaceutical compositions for use in the treatment herpes simplex virus infections
GR3023611T3 (en) Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections
EP0437026A3 (en) Use of tandospirone in the treatment of depression
IL107755A0 (en) Pharmacuetical compositions for the treatment and prophylaxis of parasitic infections
EP0735897A4 (en) ALLERGY PROPHYLAXIS
GB9419692D0 (en) Treatment of herpes infections
IL116827A (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for vasodilatory treatment and prophylaxis
IL111138A0 (en) Pharmaceutical compositons comprising penciclovir and/or its derivatives for the treatment (including prophylaxis) of phn
HU9500120D0 (en) Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
HUP9802450A3 (en) Use of prostane derivatives and the combination thereof for preparing pharmaceutical compositions for use in treatment of bacterial infections
GB2279567B (en) Compositions for the treatment of inflammatory proliferative skin disease and their use
ZA903044B (en) Interferon for the use in the prevention or treatment of swine pneumonia or related bacterial diseases
EP0643586A4 (en) COMPOSITIONS FOR USE IN THE DIAGNOSIS AND PROPHYLAXIS OF LYME DISEASE.

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD., BM

HFG4 Patent granted, date of granting

Effective date: 20031008